Turkey Diagnostics Imaging Market By Type (X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, and Nuclear Imaging Solutions), By Mobility (Portable, Standalone), By Source (Domestic, Import), By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers, Others), By Region, Competition Forecast & Opportunities, 2028F
Turkey Diagnostics Imaging Market is expected to grow at an impressive rate during the forecast period, 2024-2028. The major factors include the increasing prevalence of chronic diseases and cancer, the growing geriatric population, the increase in the number of screenings and testing, gaining the interest of the government, and medical and healthcare advancements, according to TURKSTAT, Turkey's economy expanded by 11% year-on-year in 2021 as per the market standards. Additionally, the lack of awareness among the public for early diagnosis and treatment is further expected to drive the growth of Turkey Diagnostics Imaging Market.
Moreover, the rise in genetic problems, sedentary lifestyles, and technological developments is expected to drive the growth of Turkey Diagnostics Imaging Market in the forecast years 2024-2028. According to the Turkish Statistical Institute (TurkStat), in 2021, the gross domestic product in Turkey is spending on research and development, with expenditure exceeding USD802.7 billion and increasing by 42.8%.
Rising prevalence of chronic diseases
Non-Communicable Diseases (NCDs), such as cancer, cardiovascular diseases, diabetes, etc., are highly threatening to the population in recent times. Their risk factors include harmful use of alcohol, tobacco use, unhealthy diet, and physical inactivity resulting in the rise of public health and development challenges. In Turkey, NCDs have a significant impact on the productivity of the population, resulting in disability and premature deaths and further hampers socioeconomic development. According to the Turkish Statistical Institute, NCDs are responsible for 87.5% of all deaths in the country. The probability of premature death (death before the age of 70 years) from one of the four major NCDs for a person living in Turkey was around one in six (16.8%) in 2015. Regular checkups and health monitoring among patients suffering from chronic diseases are attributed to the growth of the diagnostic imaging market and, at the same time, are anticipated to propel market growth in the coming years.
Rising geriatric population’s susceptibility to disease
The early aging process is expected to drive the growth of Turkey diagnostics imaging market. This is due to a lack of physical activity and the translation of hereditary problems. According to the WHO reports Turkish citizens have around a 16.8% chance of dying prematurely, i.e., before the age of 70 years. And the probability of having NCD for men is more as compared to women, i.e., 22.5% and 11.6%, respectively. This results in a significant opportunity to make progress on the United Nations Sustainable Development Goal target 3.4, which aims to reduce premature mortality from NCDs by one-third by 2030. Furthermore, the need to utilize diagnostic imaging procedures for chronic diseases in the elderly to maintain the health parameter by regular diagnosis is expected to support the growth of Turkey Diagnostics Imaging Market.
Growing Medical Tourism Infrastructure Development
Turkey is an excellent provider of medical tourism for countries across the world. The country is at a central location for many cities in Europe and Middle East region and holds an excellent capacity of tourists regarding medical tourism facilities. Also, medical tourism facilities get to include significant exposure to healthcare products, including diagnostic imaging services like X-rays, ultrasounds, CT scans, MRIs, etc. These diagnostic processes are utilized for verifying the presence of illnesses in the patient. For instance, according to a survey by the Positive Living Association, while the average number of new HIV incident cases has decreased internationally, it has climbed in Turkey, where it went from 0.7 per 100,000 people in 2009 to 3.9 per 100,000 people in 2019. Thus, frequent diagnostic imaging, such as chest X-rays, ultrasound, etc., are performed on the patient to keep records and check the health of patients suffering through the disease, thereby propelling the diagnostic imaging market demand and attributing to the market growth. Moreover, the country with cost-efficient availability for medical facilities and treatments for the people coming for medical facilities in Turkey supports diagnostic imaging and thereby propels the market growth in the forecast period.
Market Segmentation
Turkey Diagnostics Imaging Market can be segmented by type, mobility, source, application, end user, and region. Based on type, the market is segmented into X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, and Nuclear Imaging Solutions. Based on mobility, the market is segmented into Portable and Standalone. Depending on the source, the market is fragmented into Domestic and Import. Depending on the application type, the market is further segmented into Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, and Others. Based on the end user, the market is further divided into Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers, and Others.
Market Players
Hoffmann-La Roche Ltd (FOUNDATION MEDICINE, INC.), Siemens Healthcare GmbH, OPKO Health, Inc. (GenPath), Myriad Genetics Inc., NeoGenomics Laboratories, Danaher. (Beckman Coulter, Inc.), Agilent Technologies, Inc., Abcam plc., Bio-Techne. (ExoDx), H.U. Group Holdings, Inc. (Fujeribio), etc., are some of the leading companies operating in the market.
Report Scope:
In this report, Turkey Diagnostics Imaging Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Turkey Diagnostics Imaging Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Moreover, the rise in genetic problems, sedentary lifestyles, and technological developments is expected to drive the growth of Turkey Diagnostics Imaging Market in the forecast years 2024-2028. According to the Turkish Statistical Institute (TurkStat), in 2021, the gross domestic product in Turkey is spending on research and development, with expenditure exceeding USD802.7 billion and increasing by 42.8%.
Rising prevalence of chronic diseases
Non-Communicable Diseases (NCDs), such as cancer, cardiovascular diseases, diabetes, etc., are highly threatening to the population in recent times. Their risk factors include harmful use of alcohol, tobacco use, unhealthy diet, and physical inactivity resulting in the rise of public health and development challenges. In Turkey, NCDs have a significant impact on the productivity of the population, resulting in disability and premature deaths and further hampers socioeconomic development. According to the Turkish Statistical Institute, NCDs are responsible for 87.5% of all deaths in the country. The probability of premature death (death before the age of 70 years) from one of the four major NCDs for a person living in Turkey was around one in six (16.8%) in 2015. Regular checkups and health monitoring among patients suffering from chronic diseases are attributed to the growth of the diagnostic imaging market and, at the same time, are anticipated to propel market growth in the coming years.
Rising geriatric population’s susceptibility to disease
The early aging process is expected to drive the growth of Turkey diagnostics imaging market. This is due to a lack of physical activity and the translation of hereditary problems. According to the WHO reports Turkish citizens have around a 16.8% chance of dying prematurely, i.e., before the age of 70 years. And the probability of having NCD for men is more as compared to women, i.e., 22.5% and 11.6%, respectively. This results in a significant opportunity to make progress on the United Nations Sustainable Development Goal target 3.4, which aims to reduce premature mortality from NCDs by one-third by 2030. Furthermore, the need to utilize diagnostic imaging procedures for chronic diseases in the elderly to maintain the health parameter by regular diagnosis is expected to support the growth of Turkey Diagnostics Imaging Market.
Growing Medical Tourism Infrastructure Development
Turkey is an excellent provider of medical tourism for countries across the world. The country is at a central location for many cities in Europe and Middle East region and holds an excellent capacity of tourists regarding medical tourism facilities. Also, medical tourism facilities get to include significant exposure to healthcare products, including diagnostic imaging services like X-rays, ultrasounds, CT scans, MRIs, etc. These diagnostic processes are utilized for verifying the presence of illnesses in the patient. For instance, according to a survey by the Positive Living Association, while the average number of new HIV incident cases has decreased internationally, it has climbed in Turkey, where it went from 0.7 per 100,000 people in 2009 to 3.9 per 100,000 people in 2019. Thus, frequent diagnostic imaging, such as chest X-rays, ultrasound, etc., are performed on the patient to keep records and check the health of patients suffering through the disease, thereby propelling the diagnostic imaging market demand and attributing to the market growth. Moreover, the country with cost-efficient availability for medical facilities and treatments for the people coming for medical facilities in Turkey supports diagnostic imaging and thereby propels the market growth in the forecast period.
Market Segmentation
Turkey Diagnostics Imaging Market can be segmented by type, mobility, source, application, end user, and region. Based on type, the market is segmented into X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, and Nuclear Imaging Solutions. Based on mobility, the market is segmented into Portable and Standalone. Depending on the source, the market is fragmented into Domestic and Import. Depending on the application type, the market is further segmented into Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, and Others. Based on the end user, the market is further divided into Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers, and Others.
Market Players
Hoffmann-La Roche Ltd (FOUNDATION MEDICINE, INC.), Siemens Healthcare GmbH, OPKO Health, Inc. (GenPath), Myriad Genetics Inc., NeoGenomics Laboratories, Danaher. (Beckman Coulter, Inc.), Agilent Technologies, Inc., Abcam plc., Bio-Techne. (ExoDx), H.U. Group Holdings, Inc. (Fujeribio), etc., are some of the leading companies operating in the market.
Report Scope:
In this report, Turkey Diagnostics Imaging Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Turkey Diagnostics Imaging Market, By Type
- X-Ray Imaging Solutions
- Ultrasound Systems
- MRI Systems
- CT Scanners
- Nuclear Imaging Solutions
- Turkey Diagnostics Imaging Market, By Mobility
- Portable
- Standalone
- Turkey Diagnostics Imaging Market, By Source
- Domestic
- Import
- Turkey Diagnostics Imaging Market, By Application
- Cancer Research Institutes
- Cardiology
- Oncology
- Neurology
- Orthopedics
- Gastroenterology
- Gynecology
- Others
- Turkey Diagnostics Imaging Market, By End User
- Hospitals & Clinics
- Diagnostic Centers
- Ambulatory Care Centers
- Others
- Turkey Pharmaceutical Market, By Region:
- Marmara Region
- Central Anatolia
- Eastern Anatolia Region
- South-Eastern Anatolia Region
- Aegean Region
- Mediterranean Region
- Black Sea Region
Company Profiles: Detailed analysis of the major companies present in Turkey Diagnostics Imaging Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. TURKEY DIAGNOSTIC IMAGING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, Nuclear Imaging Solutions)
5.2.2. By Mobility (Portable v/s Standalone)
5.2.3. By Source (Domestic v/s Import)
5.2.4. By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Others)
5.2.5. By End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers, Others)
5.2.6. By Company (2022)
5.2.7. By Region
5.3. Product Market Map
6. TURKEY X-RAY IMAGING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Mobility
6.2.2. By Source
6.2.3. By End Users
7. TURKEY ULTRASOUND SYSTEMS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Mobility
7.2.2. By Source
7.2.3. By End Users
8. TURKEY MRI SYSTEMS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Mobility
8.2.2. By Source
8.2.3. By End Users
9. TURKEY CT SCANNERS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Mobility
9.2.2. By Source
9.2.3. By End Users
10. TURKEY NUCLEAR IMAGING SOLUTIONS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Mobility
10.2.2. By Source
10.2.3. By End Users
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Developments
13. POLICY & REGULATORY LANDSCAPE
14. TURKEY ECONOMIC PROFILE
15. COMPETITIVE LANDSCAPE
15.1. Business Overview
15.2. Company Snapshot
15.3. Products & Services
15.4. Financials (In case of listed companies)
15.5. Recent Developments
15.6. SWOT Analysis
15.6.1. Canon Medical Systems Corporation Turkey
15.6.2. XERA MEDICAL SYSTEMS & TECHNOLOGY CO. LTD
15.6.3. FUJIFILM DIS TICARET AS
15.6.4. GE HealthCare Technologies Inc
15.6.5. Siemens Healthineers Hakk?nda
15.6.6. Turk Philips Ticaret AS
15.6.7. SHIMADZU Middle East & Africa
15.6.8. Toshiba Medical Systems Corporation ('TMSC')
15.6.9. Inter-Med A.S
15.6.10. Esaote Biomedica Medical Systems Inc.
16. STRATEGIC RECOMMENDATIONS
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. TURKEY DIAGNOSTIC IMAGING MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, Nuclear Imaging Solutions)
5.2.2. By Mobility (Portable v/s Standalone)
5.2.3. By Source (Domestic v/s Import)
5.2.4. By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Others)
5.2.5. By End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers, Others)
5.2.6. By Company (2022)
5.2.7. By Region
5.3. Product Market Map
6. TURKEY X-RAY IMAGING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Mobility
6.2.2. By Source
6.2.3. By End Users
7. TURKEY ULTRASOUND SYSTEMS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Mobility
7.2.2. By Source
7.2.3. By End Users
8. TURKEY MRI SYSTEMS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Mobility
8.2.2. By Source
8.2.3. By End Users
9. TURKEY CT SCANNERS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Mobility
9.2.2. By Source
9.2.3. By End Users
10. TURKEY NUCLEAR IMAGING SOLUTIONS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Mobility
10.2.2. By Source
10.2.3. By End Users
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Developments
13. POLICY & REGULATORY LANDSCAPE
14. TURKEY ECONOMIC PROFILE
15. COMPETITIVE LANDSCAPE
15.1. Business Overview
15.2. Company Snapshot
15.3. Products & Services
15.4. Financials (In case of listed companies)
15.5. Recent Developments
15.6. SWOT Analysis
15.6.1. Canon Medical Systems Corporation Turkey
15.6.2. XERA MEDICAL SYSTEMS & TECHNOLOGY CO. LTD
15.6.3. FUJIFILM DIS TICARET AS
15.6.4. GE HealthCare Technologies Inc
15.6.5. Siemens Healthineers Hakk?nda
15.6.6. Turk Philips Ticaret AS
15.6.7. SHIMADZU Middle East & Africa
15.6.8. Toshiba Medical Systems Corporation ('TMSC')
15.6.9. Inter-Med A.S
15.6.10. Esaote Biomedica Medical Systems Inc.
16. STRATEGIC RECOMMENDATIONS
